Tag: Apixaban
ARTESIA shows reduced rate of stroke and embolism in sub-clinical AF...
Use of apixaban in patients with sub-clinical atrial fibrillation (AF) resulted in a lower risk of stroke or systemic embolism than aspirin, but a...
Apixaban associated with lower risk of gastrointestinal bleeding in AF patients...
Use of apixaban was associated with a lower risk of gastrointestinal bleed and similar rates of ischaemic stroke or systemic embolism, intracranial haemorrhage and...
Rates of stroke and embolism lower with apixaban compared to rivaroxaban
In a large, population-based study of patients with atrial fibrillation (AF) and valvular heart disease, those receiving apixaban had a lower risk for ischaemic...
Use of apixaban prior to cardioversion reduces risk of stroke
According to the results of the EMANATE trial, patients with atrial fibrillation (AF) who receive apixaban (Eliquis, Bristol-Myers Squibb/Pfizer) before undergoing elective cardioversion of...
ESC 2017: Apixaban lowers risk of stroke in atrial fibrillation patients...
Data from the EMANATE trial, which was presented at a Hot Line session of the European Society of Cardiology (ESC) congress (26–30 August, Barcelona,...